These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16711334)

  • 1. Sentinel lymph node scintigraphy and radioguided dissection in breast carcinoma: an initial experience at Aga Khan University Hospital.
    Zaman MU; Khan S; Hussain R; Ahmed MN
    J Pak Med Assoc; 2006 Apr; 56(4):153-6. PubMed ID: 16711334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer.
    Usmani S; Khan HA; abu Huda F; Ahmed N; al Nafisi N; Marafi F; al Mohannadi S; Javed A; Amanguno HG; Al Saleh N
    Hell J Nucl Med; 2010; 13(1):30-4. PubMed ID: 20411168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
    Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
    Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
    Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
    J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma.
    Barros AC; Barros MA; Andrade FE; Mori LJ; Costa PA; Sheng PY; Pelizon CH
    Ann Surg Oncol; 2007 Apr; 14(4):1472-7. PubMed ID: 17225979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sentinel node biopsy in breast cancer and primary tumor dimension].
    Basta P; Tomaszewska R; Pityński K; Opławski M; Basta A
    Ginekol Pol; 2003 Sep; 74(9):666-70. PubMed ID: 14674105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probe.
    Mariani G; Villa G; Gipponi M; Bianchi P; Buffoni F; Agnese G; Vecchio C; Tomei D; Carli F; Nicolò G; Canavese G
    Cancer Biother Radiopharm; 2000 Jun; 15(3):245-52. PubMed ID: 10941531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit of using two techniques for sentinel lymph node mapping in breast cancer.
    Sardi A; Spiegler E; Colandrea J; Frishberg D; Sing H; Regan P; Totoonchie A; Merchant D; Hochuli S; Setya V; Singer JA
    Am Surg; 2002 Jan; 68(1):24-8. PubMed ID: 12467312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.